The blood–retina barrier in health and disease

The blood–retina barrier (BRB) is the term used to define the properties of the retinal capillaries and the retinal pigment epithelium (RPE), which separate the systemic circulation from the retina. More specifically, the inner blood–retina barrier (iBRB) is used to describe the properties of the en...

Full description

Saved in:
Bibliographic Details
Published inThe FEBS journal Vol. 290; no. 4; pp. 878 - 891
Main Authors O’Leary, Fionn, Campbell, Matthew
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.02.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The blood–retina barrier (BRB) is the term used to define the properties of the retinal capillaries and the retinal pigment epithelium (RPE), which separate the systemic circulation from the retina. More specifically, the inner blood–retina barrier (iBRB) is used to describe the properties of the endothelial cells that line the microvasculature of the inner retina, while the outer blood–retina barrier (oBRB) refers to the properties of the RPE cells that separate the fenestrated choriocapillaris from the retina. The BRB is not a fixed structure; rather, it is dynamic, with its components making unique contributions to its function and structural integrity, and therefore the retina. For example, while tight junction (TJ) proteins between retinal endothelial cells are the key molecular structures in the maintenance of the iBRB, other cell types surrounding endothelial cells are also important. In fact, this overall structure is termed the neurovascular unit (NVU). The integrity of the BRB is crucial in the maintenance of a ‘dry’, tightly regulated retinal microenvironment through the regulation of transcellular and paracellular transport. Specifically, breakdown of TJs can result in oedema formation, a hallmark feature of many retinal diseases. Here, we will describe the oBRB briefly, with a more in‐depth focus on the structure and function of the iBRB in health and diseased states. Finally, the contribution of the BRB to the pathophysiology of age‐related macular degeneration (AMD), diabetic retinopathy (DR) and other rarer retinal diseases will be discussed. The inner blood–retina barrier (iBRB) refers to the properties of endothelial cells associated with the blood vessels of the inner retina. These cells strictly regulate entry and exit from the retina and perturbations in their function have detrimental effects on vision and lead to conditions such as diabetic retinopathy (DR) and age‐related macular degeneration (AMD). This review provides a succinct overview of BRB breakdown‐associated retinal conditions and the putative underlying mechanisms of disease.
AbstractList The blood-retina barrier (BRB) is the term used to define the properties of the retinal capillaries and the retinal pigment epithelium (RPE), which separate the systemic circulation from the retina. More specifically, the inner blood-retina barrier (iBRB) is used to describe the properties of the endothelial cells that line the microvasculature of the inner retina, while the outer blood-retina barrier (oBRB) refers to the properties of the RPE cells that separate the fenestrated choriocapillaris from the retina. The BRB is not a fixed structure; rather, it is dynamic, with its components making unique contributions to its function and structural integrity, and therefore the retina. For example, while tight junction (TJ) proteins between retinal endothelial cells are the key molecular structures in the maintenance of the iBRB, other cell types surrounding endothelial cells are also important. In fact, this overall structure is termed the neurovascular unit (NVU). The integrity of the BRB is crucial in the maintenance of a 'dry', tightly regulated retinal microenvironment through the regulation of transcellular and paracellular transport. Specifically, breakdown of TJs can result in oedema formation, a hallmark feature of many retinal diseases. Here, we will describe the oBRB briefly, with a more in-depth focus on the structure and function of the iBRB in health and diseased states. Finally, the contribution of the BRB to the pathophysiology of age-related macular degeneration (AMD), diabetic retinopathy (DR) and other rarer retinal diseases will be discussed.The blood-retina barrier (BRB) is the term used to define the properties of the retinal capillaries and the retinal pigment epithelium (RPE), which separate the systemic circulation from the retina. More specifically, the inner blood-retina barrier (iBRB) is used to describe the properties of the endothelial cells that line the microvasculature of the inner retina, while the outer blood-retina barrier (oBRB) refers to the properties of the RPE cells that separate the fenestrated choriocapillaris from the retina. The BRB is not a fixed structure; rather, it is dynamic, with its components making unique contributions to its function and structural integrity, and therefore the retina. For example, while tight junction (TJ) proteins between retinal endothelial cells are the key molecular structures in the maintenance of the iBRB, other cell types surrounding endothelial cells are also important. In fact, this overall structure is termed the neurovascular unit (NVU). The integrity of the BRB is crucial in the maintenance of a 'dry', tightly regulated retinal microenvironment through the regulation of transcellular and paracellular transport. Specifically, breakdown of TJs can result in oedema formation, a hallmark feature of many retinal diseases. Here, we will describe the oBRB briefly, with a more in-depth focus on the structure and function of the iBRB in health and diseased states. Finally, the contribution of the BRB to the pathophysiology of age-related macular degeneration (AMD), diabetic retinopathy (DR) and other rarer retinal diseases will be discussed.
The blood–retina barrier (BRB) is the term used to define the properties of the retinal capillaries and the retinal pigment epithelium (RPE), which separate the systemic circulation from the retina. More specifically, the inner blood–retina barrier (iBRB) is used to describe the properties of the endothelial cells that line the microvasculature of the inner retina, while the outer blood–retina barrier (oBRB) refers to the properties of the RPE cells that separate the fenestrated choriocapillaris from the retina. The BRB is not a fixed structure; rather, it is dynamic, with its components making unique contributions to its function and structural integrity, and therefore the retina. For example, while tight junction (TJ) proteins between retinal endothelial cells are the key molecular structures in the maintenance of the iBRB, other cell types surrounding endothelial cells are also important. In fact, this overall structure is termed the neurovascular unit (NVU). The integrity of the BRB is crucial in the maintenance of a ‘dry’, tightly regulated retinal microenvironment through the regulation of transcellular and paracellular transport. Specifically, breakdown of TJs can result in oedema formation, a hallmark feature of many retinal diseases. Here, we will describe the oBRB briefly, with a more in‐depth focus on the structure and function of the iBRB in health and diseased states. Finally, the contribution of the BRB to the pathophysiology of age‐related macular degeneration (AMD), diabetic retinopathy (DR) and other rarer retinal diseases will be discussed.
The blood–retina barrier (BRB) is the term used to define the properties of the retinal capillaries and the retinal pigment epithelium (RPE), which separate the systemic circulation from the retina. More specifically, the inner blood–retina barrier (iBRB) is used to describe the properties of the endothelial cells that line the microvasculature of the inner retina, while the outer blood–retina barrier (oBRB) refers to the properties of the RPE cells that separate the fenestrated choriocapillaris from the retina. The BRB is not a fixed structure; rather, it is dynamic, with its components making unique contributions to its function and structural integrity, and therefore the retina. For example, while tight junction (TJ) proteins between retinal endothelial cells are the key molecular structures in the maintenance of the iBRB, other cell types surrounding endothelial cells are also important. In fact, this overall structure is termed the neurovascular unit (NVU). The integrity of the BRB is crucial in the maintenance of a ‘dry’, tightly regulated retinal microenvironment through the regulation of transcellular and paracellular transport. Specifically, breakdown of TJs can result in oedema formation, a hallmark feature of many retinal diseases. Here, we will describe the oBRB briefly, with a more in‐depth focus on the structure and function of the iBRB in health and diseased states. Finally, the contribution of the BRB to the pathophysiology of age‐related macular degeneration (AMD), diabetic retinopathy (DR) and other rarer retinal diseases will be discussed. The inner blood–retina barrier (iBRB) refers to the properties of endothelial cells associated with the blood vessels of the inner retina. These cells strictly regulate entry and exit from the retina and perturbations in their function have detrimental effects on vision and lead to conditions such as diabetic retinopathy (DR) and age‐related macular degeneration (AMD). This review provides a succinct overview of BRB breakdown‐associated retinal conditions and the putative underlying mechanisms of disease.
Author Campbell, Matthew
O’Leary, Fionn
Author_xml – sequence: 1
  givenname: Fionn
  surname: O’Leary
  fullname: O’Leary, Fionn
  organization: Trinity College Dublin
– sequence: 2
  givenname: Matthew
  orcidid: 0000-0003-3325-240X
  surname: Campbell
  fullname: Campbell, Matthew
  email: matthew.campbell@tcd.ie
  organization: Trinity College Dublin
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34923749$$D View this record in MEDLINE/PubMed
BookMark eNqF0ctKAzEUBuAgFWurGx9ABtyIUM3lTC5LLfUCBRdWcBcykwxNmc7UZIp05zv4hj6JU6suimg2CeQ7PyR_D3WqunIIHRF8Ttp1UbgsnhPOGN5B-0QAHQBPZefnDE9d1ItxhjFLQak91GWgKBOg9hGeTF2SlXVt31_fgmt8ZZLMhOBdSHyVTJ0pm2liKptYH52J7gDtFqaM7vBr76PH69FkeDsY39_cDS_Hg7zNxgPIMVhrlZESywIEiDQDJwgUlnMDktocuMTYSpNmQgLjGcWE8UIo2t4b1kenm9xFqJ-XLjZ67mPuytJUrl5GTSUhSiig9H_KCcVMCLKmJ1t0Vi9D1T5EUyG4ogpS1qrjL7XM5s7qRfBzE1b6-9tagDcgD3WMwRU6941pfF01wfhSE6zXzeh1M_qzmXbkbGvkO_VXTDb4xZdu9YfU16Orh83MBxp9mv8
CitedBy_id crossref_primary_10_1002_smtd_202402048
crossref_primary_10_3390_futurepharmacol4020019
crossref_primary_10_1002_advs_202403399
crossref_primary_10_31083_j_fbl2812363
crossref_primary_10_1016_j_plefa_2024_102637
crossref_primary_10_1038_s41423_023_01088_9
crossref_primary_10_1016_j_phymed_2023_155097
crossref_primary_10_3390_ijms25126404
crossref_primary_10_1021_acs_jproteome_2c00506
crossref_primary_10_1016_j_bbrc_2024_150078
crossref_primary_10_3389_fcell_2022_887764
crossref_primary_10_1021_acs_est_4c02179
crossref_primary_10_1096_fj_202302624R
crossref_primary_10_55959_MSU0137_0952_16_78_3_8
crossref_primary_10_1016_j_jlr_2023_100401
crossref_primary_10_1016_j_preteyeres_2024_101321
crossref_primary_10_3390_ijms242015352
crossref_primary_10_1016_j_jconrel_2024_01_063
crossref_primary_10_3390_biomedicines12040817
crossref_primary_10_1186_s12987_023_00430_7
crossref_primary_10_2174_1389201025666230907145019
crossref_primary_10_1186_s12974_024_03058_y
crossref_primary_10_1002_admt_202400634
crossref_primary_10_1007_s11064_024_04145_5
crossref_primary_10_47162_RJME_65_3_01
crossref_primary_10_1186_s12974_024_03064_0
crossref_primary_10_1016_j_mvr_2024_104682
crossref_primary_10_1016_j_addr_2023_115005
crossref_primary_10_1016_j_phrs_2023_106946
crossref_primary_10_1080_1061186X_2024_2443144
crossref_primary_10_1186_s12987_022_00386_0
crossref_primary_10_3390_cells11111733
crossref_primary_10_3390_s24165227
crossref_primary_10_1007_s12024_024_00874_9
crossref_primary_10_1016_j_jhazmat_2024_135376
crossref_primary_10_1016_j_exer_2024_109980
crossref_primary_10_3103_S0096392523700098
crossref_primary_10_1101_cshperspect_a041763
crossref_primary_10_1016_j_ijbiomac_2024_139017
crossref_primary_10_3389_fmed_2024_1445180
crossref_primary_10_1111_cen3_12812
crossref_primary_10_3390_ph16030435
crossref_primary_10_3389_fviro_2022_892394
crossref_primary_10_3390_bioengineering11121247
crossref_primary_10_1002_med_22036
crossref_primary_10_1016_j_biopha_2025_117940
crossref_primary_10_1126_sciadv_ads4412
crossref_primary_10_1016_j_bcp_2024_116311
crossref_primary_10_1126_sciadv_adn6379
crossref_primary_10_3389_fpubh_2024_1365828
crossref_primary_10_3390_ijms25042124
crossref_primary_10_1242_dmm_050640
crossref_primary_10_1186_s12974_024_03190_9
crossref_primary_10_3390_ijms232214196
crossref_primary_10_1093_postmj_qgae046
crossref_primary_10_3389_fimmu_2024_1374617
crossref_primary_10_3389_fendo_2023_1234824
crossref_primary_10_1016_j_molmet_2023_101736
crossref_primary_10_37349_ebmx_2024_00023
crossref_primary_10_1016_j_jphs_2025_02_002
crossref_primary_10_1038_s41598_024_67587_5
crossref_primary_10_1007_s11357_024_01489_2
crossref_primary_10_1186_s40942_025_00643_y
crossref_primary_10_1055_a_2528_7886
crossref_primary_10_4103_NRR_NRR_D_23_02033
crossref_primary_10_1186_s13578_024_01269_7
crossref_primary_10_3390_ijtm4040049
crossref_primary_10_1016_j_heliyon_2023_e15202
crossref_primary_10_1016_j_preteyeres_2024_101245
crossref_primary_10_3390_antiox12111979
crossref_primary_10_1016_j_ymgme_2023_107648
crossref_primary_10_3390_cells11213453
crossref_primary_10_1111_jcmm_70442
crossref_primary_10_1002_bies_202300197
crossref_primary_10_1111_eci_14319
crossref_primary_10_1186_s12974_024_03075_x
crossref_primary_10_3389_fmed_2022_973856
crossref_primary_10_3390_vetsci11010002
crossref_primary_10_1016_j_arr_2024_102446
crossref_primary_10_3389_fnmol_2023_1100254
crossref_primary_10_3389_fnins_2022_1009599
crossref_primary_10_3390_futurepharmacol4030027
crossref_primary_10_1515_revneuro_2023_0130
crossref_primary_10_1126_scitranslmed_abq5068
crossref_primary_10_3389_fcell_2023_1195873
crossref_primary_10_3390_jcm12134332
crossref_primary_10_3390_ijms252212271
crossref_primary_10_1016_j_preteyeres_2023_101217
crossref_primary_10_3389_fimmu_2023_1148037
crossref_primary_10_1073_pnas_2402560121
crossref_primary_10_1016_j_addr_2023_114842
crossref_primary_10_2147_CIA_S463297
crossref_primary_10_1002_cpt_3230
crossref_primary_10_14336_AD_2024_0922
crossref_primary_10_1016_j_preteyeres_2023_101187
crossref_primary_10_1021_acsomega_4c06546
crossref_primary_10_1016_j_exer_2024_110101
crossref_primary_10_1016_j_preteyeres_2023_101189
crossref_primary_10_1186_s12974_025_03391_w
crossref_primary_10_1055_a_2063_8957
crossref_primary_10_3390_ph17091190
crossref_primary_10_1021_acs_est_4c12051
crossref_primary_10_1016_j_bioactmat_2023_08_003
crossref_primary_10_7554_eLife_91141
crossref_primary_10_1016_j_arr_2022_101735
crossref_primary_10_1155_bmri_6654976
crossref_primary_10_3390_cells14020085
crossref_primary_10_1016_j_brainres_2024_149253
crossref_primary_10_1186_s12951_024_02614_1
crossref_primary_10_7554_eLife_91141_3
crossref_primary_10_3389_fphys_2024_1408605
Cites_doi 10.1016/j.preteyeres.2011.06.002
10.1093/cvr/cvq086
10.1016/j.preteyeres.2009.08.003
10.1006/bbrc.1998.9790
10.1038/nature13324
10.1172/jci.insight.130273
10.1152/physrev.00021.2004
10.1083/jcb.150.5.1057
10.3390/ijms21051636
10.1038/nrm3512
10.1016/j.preteyeres.2013.02.001
10.1016/j.exer.2006.01.032
10.2174/09298673113209990022
10.1146/annurev-vision-091517-034018
10.2337/diacare.27.2007.S84
10.1152/physrev.00019.2012
10.3389/fnins.2019.00991
10.1155/2010/190724
10.1038/s41433-020-0961-6
10.2337/diabetes.53.4.1104
10.1016/S0140-6736(06)69740-7
10.1016/j.addr.2005.01.005
10.1186/s40662-021-00239-1
10.3390/ijms21124271
10.1038/ng.3311
10.1076/0271-3683(200008)2121-VFT637
10.2337/db09-1606
10.1023/A:1002192829817
10.1007/s00018-019-03177-3
10.1136/bmjopen-2012-002269
10.1016/S0074-7696(07)58004-6
10.1371/journal.pone.0052152
10.3390/cells10010064
10.3389/fncel.2016.00020
10.1055/s-2005-861361
10.1152/ajpcell.00547.2002
10.1038/jcbfm.2013.230
10.5301/EJO.2010.6049
10.1016/j.ajpath.2015.11.019
10.1007/978-981-13-7647-4_1
10.1136/bjo.55.5.289
10.1083/jcb.200302070
10.1146/annurev.cellbio.22.010305.104219
10.1083/jcb.200304039
10.1016/0002-9394(86)90831-7
10.1091/mbc.E09-08-0734
10.1152/ajpheart.00803.2011
10.1152/physrev.00035.2003
10.4103/ijo.IJO_449_19
10.1186/gb-2009-10-8-235
10.1177/1120672120919337
10.1167/iovs.10-5984
10.4103/ijo.IJO_841_19
10.1016/j.preteyeres.2015.06.003
10.1016/S0140-6736(18)31550-2
10.1016/j.preteyeres.2017.10.006
10.1074/jbc.M905251199
10.1038/bjp.2008.48
10.1167/iovs.03-0913
10.1159/000455809
10.1038/nrn1824
10.1002/jps.22610
10.1016/S2214-109X(13)70145-1
10.1159/000078617
10.1155/2018/8374647
10.1371/journal.pone.0144156
10.1073/pnas.0808698106
10.1007/s40273-020-00953-z
10.1016/S0065-2776(04)86005-X
10.1152/ajpcell.00038.2002
10.1016/j.exer.2010.02.013
10.1515/hsz-2012-0316
10.1167/iovs.06-0619
10.1016/j.preteyeres.2020.100878
10.1111/j.1476-5381.2010.01024.x
10.1007/s00417-016-3548-y
10.1038/nm1534
10.1016/j.brainres.2017.07.025
10.1167/iovs.06-1358
10.1016/S0006-3495(03)74975-3
10.1016/j.pneurobio.2011.05.011
10.1074/jbc.274.33.23463
10.1371/journal.pone.0108508
10.1098/rstb.2014.0195
10.1016/j.preteyeres.2016.04.003
10.1016/j.survophthal.2017.09.009
10.1161/ATVBAHA.111.224626
10.2337/db11-1367
10.1038/nrm1357
10.2174/156652410793937813
10.1242/jcs.111.13.1853
10.1523/JNEUROSCI.1142-19.2019
10.2337/diabetes.55.02.06.db05-1103
10.1016/S0002-9440(10)61231-X
10.1371/journal.pone.0078954
10.1016/j.ajpath.2013.10.022
10.3928/01913913-20190716-01
10.1083/jcb.141.2.397
10.1016/j.ophtha.2021.04.027
10.1016/j.exer.2014.03.005
10.3390/jcm3041302
10.1016/j.peptides.2012.02.008
10.1074/jbc.M116.721340
10.1097/IAE.0b013e3182993e09
10.1186/1746-1596-1-24
10.1016/j.exer.2019.05.026
ContentType Journal Article
Copyright 2021 Federation of European Biochemical Societies
2021 Federation of European Biochemical Societies.
Copyright © 2023 Federation of European Biochemical Societies
Copyright_xml – notice: 2021 Federation of European Biochemical Societies
– notice: 2021 Federation of European Biochemical Societies.
– notice: Copyright © 2023 Federation of European Biochemical Societies
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QP
7QR
7TK
7TM
7U9
8FD
C1K
FR3
H94
M7N
P64
RC3
7X8
7S9
L.6
DOI 10.1111/febs.16330
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Technology Research Database
Nucleic Acids Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
Genetics Abstracts
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE - Academic
AGRICOLA
CrossRef
Virology and AIDS Abstracts

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1742-4658
EndPage 891
ExternalDocumentID 34923749
10_1111_febs_16330
FEBS16330
Genre reviewArticle
Research Support, Non-U.S. Gov't
Journal Article
Review
GrantInformation_xml – fundername: Campbell laboratory is funded by the Irish Research Council (IRC)
  funderid: 16/RC/3948
– fundername: H2020 European Research Council
  funderid: 864522
GroupedDBID ---
-DZ
-~X
.3N
.55
.GA
.Y3
05W
0R~
10A
1OC
24P
29H
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
A8Z
AAESR
AAEVG
AAHBH
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEFU
ABEML
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACIWK
ACMXC
ACNCT
ACPOU
ACPRK
ACSCC
ACUHS
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C1A
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
E3Z
EAD
EAP
EAS
EAU
EBB
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
EST
ESX
EX3
F00
F01
F04
F5P
FIJ
FUBAC
G-S
G.N
GODZA
GX1
H.X
HF~
HGLYW
HH5
HZI
HZ~
IHE
IX1
J0M
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MVM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OBS
OIG
OK1
OVD
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
RNS
ROL
RX1
SUPJJ
SV3
TEORI
TR2
TUS
UB1
V8K
W8V
W99
WBFHL
WBKPD
WIH
WIJ
WIK
WIN
WOHZO
WOQ
WOW
WQJ
WRC
WXI
WXSBR
WYISQ
X7M
XG1
Y6R
~IA
~KM
~WT
AAYXX
AEYWJ
AGHNM
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QP
7QR
7TK
7TM
7U9
8FD
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
C1K
FR3
H94
M7N
P64
RC3
7X8
7S9
L.6
ID FETCH-LOGICAL-c4920-4c04ddd9a8808f47475b4e714fd66a482dc46800d8a5b78436b20136f7926a4a3
IEDL.DBID DR2
ISSN 1742-464X
1742-4658
IngestDate Fri Jul 11 18:39:13 EDT 2025
Fri Jul 11 12:33:55 EDT 2025
Fri Jul 25 19:38:35 EDT 2025
Thu Apr 03 07:07:01 EDT 2025
Tue Jul 01 03:07:15 EDT 2025
Thu Apr 24 23:06:23 EDT 2025
Wed Jan 22 16:16:37 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords neurovascular
barrier
retina
blood
tight junction
Language English
License 2021 Federation of European Biochemical Societies.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4920-4c04ddd9a8808f47475b4e714fd66a482dc46800d8a5b78436b20136f7926a4a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0003-3325-240X
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.16330
PMID 34923749
PQID 2776929453
PQPubID 28478
PageCount 891
ParticipantIDs proquest_miscellaneous_2811979422
proquest_miscellaneous_2612037712
proquest_journals_2776929453
pubmed_primary_34923749
crossref_citationtrail_10_1111_febs_16330
crossref_primary_10_1111_febs_16330
wiley_primary_10_1111_febs_16330_FEBS16330
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 2023
PublicationDateYYYYMMDD 2023-02-01
PublicationDate_xml – month: 02
  year: 2023
  text: February 2023
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle The FEBS journal
PublicationTitleAlternate FEBS J
PublicationYear 2023
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References 2010; 11
2010; 10
2013; 3
2010; 13
1997; 150
2004; 27
2019; 13
2011; 52
2004; 5
2013; 8
2015; 370
2010; 21
2009; 10
2018; 4
2010; 29
1986; 101
2006; 22
2017; 1672
2003; 161
2004; 218
2014; 122
2021; 80
2003; 284
1990; 31
2019; 4
2010; 2010
2006; 55
2004; 45
2016; 10
2019; 39
2005; 85
2020; 38
2013; 93
2005; 86
2020; 34
2017; 255
2012; 34
2007; 13
2019; 186
2011; 301
2004; 53
2020; 30
2011; 95
2020; 21
2016; 291
2014; 34
1998; 141
2009; 106
2012; 61
2010; 59
2021; 128
2019; 56
2013; 20
1998; 111
2016; 186
2017; 237
2007; 258
1971; 55
2015; 47
2013; 14
2014; 3
2014; 2
2019; 67
2011; 21
1999; 97
1999; 256
2013; 394
2014; 9
2005; 37
2011; 162
2006; 368
2003; 84
2008; 154
2021; 8
2004; 84
2019; 76
2000; 21
2015; 10
1995; 10
2006; 7
2016; 54
2011; 31
2011; 30
2000; 150
2016; 51
2018; 63
2000; 275
2006; 1
2019; 1141
2015; 8
2017; 94
2010; 87
2021; 10
2018; 2018
1976; 13
2006; 83
2018; 392
2005; 167
2002; 283
2014; 509
2013; 34
1999; 274
2014; 184
2012; 7
2010; 90
2011; 100
2005; 57
2007; 48
e_1_2_22_90_1
e_1_2_22_71_1
e_1_2_22_94_1
e_1_2_22_115_1
e_1_2_22_75_1
e_1_2_22_98_1
e_1_2_22_111_1
e_1_2_22_26_1
e_1_2_22_79_1
Pruneau D (e_1_2_22_81_1) 2010; 11
e_1_2_22_14_1
e_1_2_22_56_1
e_1_2_22_33_1
e_1_2_22_10_1
e_1_2_22_108_1
e_1_2_22_52_1
Frank RN (e_1_2_22_16_1) 1990; 31
e_1_2_22_60_1
e_1_2_22_83_1
e_1_2_22_103_1
e_1_2_22_19_1
e_1_2_22_64_1
e_1_2_22_87_1
e_1_2_22_15_1
e_1_2_22_38_1
e_1_2_22_68_1
e_1_2_22_5_1
e_1_2_22_22_1
e_1_2_22_45_1
Egbert PR (e_1_2_22_113_1) 1976; 13
e_1_2_22_41_1
e_1_2_22_70_1
e_1_2_22_93_1
e_1_2_22_114_1
e_1_2_22_74_1
e_1_2_22_97_1
e_1_2_22_110_1
e_1_2_22_29_1
e_1_2_22_78_1
e_1_2_22_48_1
e_1_2_22_13_1
e_1_2_22_36_1
Andreone BJ (e_1_2_22_54_1) 2017; 94
e_1_2_22_9_1
e_1_2_22_55_1
e_1_2_22_32_1
e_1_2_22_107_1
e_1_2_22_51_1
Hookes L (e_1_2_22_82_1) 2010; 13
e_1_2_22_63_1
e_1_2_22_86_1
e_1_2_22_106_1
e_1_2_22_18_1
e_1_2_22_67_1
e_1_2_22_4_1
e_1_2_22_37_1
e_1_2_22_102_1
e_1_2_22_25_1
e_1_2_22_44_1
e_1_2_22_21_1
e_1_2_22_40_1
e_1_2_22_92_1
e_1_2_22_73_1
e_1_2_22_96_1
e_1_2_22_28_1
e_1_2_22_77_1
e_1_2_22_58_1
e_1_2_22_35_1
e_1_2_22_8_1
e_1_2_22_12_1
e_1_2_22_31_1
e_1_2_22_50_1
e_1_2_22_62_1
e_1_2_22_85_1
e_1_2_22_3_1
e_1_2_22_105_1
e_1_2_22_17_1
e_1_2_22_66_1
e_1_2_22_89_1
e_1_2_22_7_1
e_1_2_22_101_1
e_1_2_22_24_1
e_1_2_22_47_1
e_1_2_22_59_1
e_1_2_22_20_1
e_1_2_22_43_1
Vinores SA (e_1_2_22_104_1) 1995; 10
e_1_2_22_72_1
e_1_2_22_95_1
e_1_2_22_76_1
e_1_2_22_99_1
e_1_2_22_57_1
e_1_2_22_112_1
e_1_2_22_27_1
e_1_2_22_11_1
e_1_2_22_34_1
e_1_2_22_53_1
e_1_2_22_109_1
e_1_2_22_30_1
e_1_2_22_80_1
e_1_2_22_61_1
e_1_2_22_2_1
e_1_2_22_84_1
e_1_2_22_65_1
e_1_2_22_6_1
Li Y (e_1_2_22_49_1) 2015; 8
e_1_2_22_39_1
e_1_2_22_88_1
e_1_2_22_100_1
e_1_2_22_69_1
e_1_2_22_46_1
e_1_2_22_23_1
e_1_2_22_42_1
Bamforth SD (e_1_2_22_91_1) 1997; 150
References_xml – volume: 10
  year: 2015
  article-title: Correlation of aging and segmental choroidal thickness measurement using swept source optical coherence tomography in healthy eyes
  publication-title: PLoS One
– volume: 48
  start-page: 2203
  year: 2007
  end-page: 7
  article-title: Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders
  publication-title: Invest Ophthalmol vis Sci
– volume: 5
  start-page: 261
  year: 2004
  end-page: 70
  article-title: Endothelial cell‐cell junctions: happy together
  publication-title: Nat Rev Mol Cell Biol
– volume: 80
  start-page: 100878
  year: 2021
  article-title: Plexus‐specific retinal vascular anatomy and pathologies as seen by projection‐resolved optical coherence tomographic angiography
  publication-title: Prog Retin Eye Res
– volume: 67
  start-page: 772
  year: 2019
  end-page: 83
  article-title: Coats disease in 351 eyes: Analysis of features and outcomes over 45 years (by decade) at a single center
  publication-title: Indian J Ophthalmol
– volume: 7
  year: 2012
  article-title: High‐glucose‐induced endothelial cell injury is inhibited by a Peptide derived from human apolipoprotein E
  publication-title: PLoS One
– volume: 1141
  start-page: 1
  year: 2019
  end-page: 12
  article-title: Overview: role of drug transporters in drug disposition and its clinical significance
  publication-title: Adv Exp Med Biol
– volume: 3
  year: 2013
  article-title: Current treatments in diabetic macular oedema: systematic review and meta‐analysis
  publication-title: BMJ Open
– volume: 93
  start-page: 525
  year: 2013
  end-page: 69
  article-title: Claudins and the modulation of tight junction permeability
  publication-title: Physiol Rev
– volume: 10
  start-page: 235
  year: 2009
  article-title: The claudins
  publication-title: Genome Biol
– volume: 4
  start-page: 130273
  year: 2019
  article-title: Dysregulated claudin‐5 cycling in the inner retina causes retinal pigment epithelial cell atrophy
  publication-title: JCI Insight
– volume: 45
  start-page: 1660
  year: 2004
  end-page: 6
  article-title: Cytoarchitecture of choroidal capillary endothelial cells
  publication-title: Invest Ophthalmol Vis Sci
– volume: 95
  start-page: 14
  year: 2011
  end-page: 25
  article-title: Age related macular degeneration and drusen: neuroinflammation in the retina
  publication-title: Prog Neurogibol
– volume: 394
  start-page: 319
  year: 2013
  end-page: 28
  article-title: Plasma kallikrein‐kinin system and diabetic retinopathy
  publication-title: Biol Chem
– volume: 1
  start-page: 24
  year: 2006
  article-title: Clinical‐histopathological correlation in a case of Coats' disease
  publication-title: Diagn Pathol
– volume: 509
  start-page: 507
  year: 2014
  end-page: 11
  article-title: Mfsd2a is critical for the formation and function of the blood‐brain barrier
  publication-title: Nature
– volume: 161
  start-page: 653
  year: 2003
  end-page: 60
  article-title: Size‐selective loosening of the blood‐brain barrier in claudin‐5‐deficient mice
  publication-title: J Cell Biol
– volume: 275
  start-page: 20520
  year: 2000
  end-page: 6
  article-title: Interaction of junctional adhesion molecule with the tight junction components ZO‐1, cingulin, and occludin
  publication-title: J Biol Chem
– volume: 14
  start-page: 98
  year: 2013
  end-page: 112
  article-title: Caveolae as plasma membrane sensors, protectors and organizers
  publication-title: Nat Rev Mol Cell Biol
– volume: 237
  start-page: 1
  year: 2017
  end-page: 10
  article-title: The blood‐retinal barrier in the management of retinal disease: EURETINA award lecture
  publication-title: Ophthalmologica
– volume: 10
  start-page: 913
  year: 1995
  end-page: 23
  article-title: Blood‐retinal barrier breakdown in retinitis pigmentosa: light and electron microscopic immunolocalization
  publication-title: Histol Histopathol
– volume: 368
  start-page: 1795
  year: 2006
  end-page: 809
  article-title: Retinitis pigmentosa
  publication-title: Lancet
– volume: 7
  start-page: 41
  year: 2006
  end-page: 53
  article-title: Astrocyte‐endothelial interactions at the blood‐brain barrier
  publication-title: Nat Rev Neurosci
– volume: 100
  start-page: 3904
  year: 2011
  end-page: 11
  article-title: Comparison of drug permeabilities across the blood‐retinal barrier, blood‐aqueous humor barrier, and blood‐brain barrier
  publication-title: J Pharm Sci
– volume: 21
  start-page: 4271
  year: 2020
  article-title: EMT and EndMT: emerging roles in age‐related macular degeneration
  publication-title: Int J Mol Sci
– volume: 52
  start-page: 1392
  year: 2011
  end-page: 403
  article-title: Claudin‐19 and the barrier properties of the human retinal pigment epithelium
  publication-title: Invest Ophthalmol vis Sci
– volume: 3
  start-page: 1302
  year: 2014
  end-page: 21
  article-title: Fundus Autofluorescence and RPE lipofuscin in age‐related macular degeneration
  publication-title: J Clin Med
– volume: 4
  start-page: 101
  year: 2018
  end-page: 22
  article-title: Retinal vasculature in development and diseases
  publication-title: Annu Rev vis Sci
– volume: 111
  start-page: 1853
  issue: Pt 13
  year: 1998
  end-page: 65
  article-title: Vascular endothelial growth factor induces VE‐cadherin tyrosine phosphorylation in endothelial cells
  publication-title: J Cell Sci
– volume: 21
  start-page: 637
  year: 2000
  end-page: 45
  article-title: VEGF‐A induced hyperpermeability of blood‐retinal barrier endothelium is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor‐A
  publication-title: Curr Eye Res
– volume: 13
  start-page: 181
  year: 2007
  end-page: 8
  article-title: Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation
  publication-title: Nat Med
– volume: 141
  start-page: 397
  year: 1998
  end-page: 408
  article-title: Occludin‐deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions
  publication-title: J Cell Biol
– volume: 106
  start-page: 1977
  year: 2009
  end-page: 82
  article-title: VEGF‐mediated disruption of endothelial CLN‐5 promotes blood‐brain barrier breakdown
  publication-title: Proc Natl Acad Sci USA
– volume: 154
  start-page: 136
  year: 2008
  end-page: 43
  article-title: Retinal plasma extravasation in streptozotocin‐diabetic rats mediated by kinin B(1) and B(2) receptors
  publication-title: Br J Pharmacol
– volume: 27
  start-page: S84
  issue: Suppl 1
  year: 2004
  end-page: 7
  article-title: Retinopathy in diabetes
  publication-title: Diabetes Care
– volume: 150
  start-page: 1057
  year: 2000
  end-page: 70
  article-title: Endothelial cell‐surface gp60 activates vesicle formation and trafficking via G(i)‐coupled Src kinase signaling pathway
  publication-title: J Cell Biol
– volume: 274
  start-page: 23463
  year: 1999
  end-page: 7
  article-title: Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors
  publication-title: J Biol Chem
– volume: 76
  start-page: 3157
  year: 2019
  end-page: 66
  article-title: Metalloproteinases mediate diabetes‐induced retinal neuropathy and vasculopathy
  publication-title: Cell Mol Life Sci
– volume: 2
  start-page: e106
  year: 2014
  end-page: 16
  article-title: Global prevalence of age‐related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta‐analysis
  publication-title: Lancet Glob Health
– volume: 34
  start-page: 19
  year: 2013
  end-page: 48
  article-title: Molecular basis of the inner blood‐retinal barrier and its breakdown in diabetic macular edema and other pathological conditions
  publication-title: Prog Retin Eye Res
– volume: 284
  start-page: C1346
  year: 2003
  end-page: 54
  article-title: Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture
  publication-title: Am J Physiol Cell Physiol
– volume: 186
  start-page: 1044
  year: 2016
  end-page: 54
  article-title: Plasmalemma vesicle‐associated protein has a key role in blood‐retinal barrier loss
  publication-title: Am J Pathol
– volume: 85
  start-page: 845
  year: 2005
  end-page: 81
  article-title: The retinal pigment epithelium in visual function
  publication-title: Physiol Rev
– volume: 31
  start-page: 999
  year: 1990
  end-page: 1007
  article-title: Pericyte coverage of retinal and cerebral capillaries
  publication-title: Invest Ophthalmol vis Sci
– volume: 21
  start-page: 1636
  year: 2020
  article-title: A new human blood‐retinal barrier model based on endothelial cells, pericytes, and astrocytes
  publication-title: Int J Mol Sci
– volume: 13
  start-page: 336
  year: 1976
  end-page: 9
  article-title: Flat preparations of the retinal vessels in Coats' disease
  publication-title: J Pediatr Ophthalmol
– volume: 392
  start-page: 1147
  year: 2018
  end-page: 59
  article-title: Age‐related macular degeneration
  publication-title: Lancet
– volume: 167
  start-page: 1451
  year: 2005
  end-page: 9
  article-title: Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function
  publication-title: Am J Pathol
– volume: 51
  start-page: 1
  year: 2016
  end-page: 40
  article-title: Glia‐neuron interactions in the mammalian retina
  publication-title: Prog Retin Eye Res
– volume: 54
  start-page: 64
  year: 2016
  end-page: 102
  article-title: Risk factors and biomarkers of age‐related macular degeneration
  publication-title: Prog Retin Eye Res
– volume: 83
  start-page: 484
  year: 2006
  end-page: 92
  article-title: Aberrant retinal tight junction and adherens junction protein expression in an animal model of autosomal dominant Retinitis pigmentosa: the Rho(‐/‐) mouse
  publication-title: Exp Eye Res
– volume: 56
  start-page: 288
  year: 2019
  end-page: 96
  article-title: Coats disease: clinical features and outcomes by age category in 351 cases
  publication-title: J Pediatr Ophthalmol Strabismus
– volume: 256
  start-page: 192
  year: 1999
  end-page: 7
  article-title: VEGF induces nuclear translocation of Flk‐1/KDR, endothelial nitric oxide synthase, and caveolin‐1 in vascular endothelial cells
  publication-title: Biochem Biophys Res Commun
– volume: 8
  start-page: 15
  year: 2021
  article-title: Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets
  publication-title: Eye vis
– volume: 63
  start-page: 20
  year: 2018
  end-page: 68
  article-title: Mechanisms of macular edema: Beyond the surface
  publication-title: Prog Retin Eye Res
– volume: 22
  start-page: 207
  year: 2006
  end-page: 35
  article-title: Tight junctions and cell polarity
  publication-title: Annu Rev Cell Dev Biol
– volume: 47
  start-page: 809
  year: 2015
  end-page: 13
  article-title: Inactivating mutations in MFSD2A, required for omega‐3 fatty acid transport in brain, cause a lethal microcephaly syndrome
  publication-title: Nat Genet
– volume: 128
  start-page: 1580
  year: 2021
  end-page: 91
  article-title: Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta‐analysis
  publication-title: Ophthalmology
– volume: 218
  start-page: 260
  year: 2004
  end-page: 3
  article-title: Levels of human tissue kallikrein in the vitreous fluid of patients with severe proliferative diabetic retinopathy
  publication-title: Ophthalmologica
– volume: 55
  start-page: 289
  year: 1971
  end-page: 301
  article-title: Electron microscopical study of Coat's disease
  publication-title: Br J Ophthalmol
– volume: 97
  start-page: 239
  year: 1999
  end-page: 49
  article-title: Mechanisms of fluid accumulation in retinal edema
  publication-title: Doc Ophthalmol
– volume: 255
  start-page: 1
  year: 2017
  end-page: 6
  article-title: The neurovascular unit and the pathophysiologic basis of diabetic retinopathy
  publication-title: Graefes Arch Clin Exp Ophthalmol
– volume: 186
  start-page: 107686
  year: 2019
  article-title: Increased serum proteins in non‐exudative AMD retinas
  publication-title: Exp Eye Res
– volume: 10
  start-page: 802
  year: 2010
  end-page: 23
  article-title: The retinal pigment epithelium in health and disease
  publication-title: Curr Mol Med
– volume: 34
  start-page: 522
  year: 2014
  end-page: 31
  article-title: Ischemia‐reperfusion injury induces occludin phosphorylation/ubiquitination and retinal vascular permeability in a VEGFR‐2‐dependent manner
  publication-title: J Cereb Blood Flow Metab
– volume: 20
  start-page: 3218
  year: 2013
  end-page: 25
  article-title: Pericyte loss in diabetic retinopathy: mechanisms and consequences
  publication-title: Curr Med Chem
– volume: 59
  start-page: 2872
  year: 2010
  end-page: 82
  article-title: TNF‐alpha signals through PKCzeta/NF‐kappaB to alter the tight junction complex and increase retinal endothelial cell permeability
  publication-title: Diabetes
– volume: 291
  start-page: 10501
  year: 2016
  end-page: 14
  article-title: Mfsd2a Is a transporter for the essential omega‐3 fatty acid docosahexaenoic Acid (DHA) in eye and is important for photoreceptor cell development
  publication-title: J Biol Chem
– volume: 150
  start-page: 329
  year: 1997
  end-page: 40
  article-title: Interleukin‐1 beta‐induced disruption of the retinal vascular barrier of the central nervous system is mediated through leukocyte recruitment and histamine
  publication-title: Am J Pathol
– volume: 53
  start-page: 1104
  year: 2004
  end-page: 10
  article-title: Angiopoietin‐2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy
  publication-title: Diabetes
– volume: 30
  start-page: 296
  year: 2011
  end-page: 323
  article-title: Integration of tight junctions and claudins with the barrier functions of the retinal pigment epithelium
  publication-title: Prog Retin Eye Res
– volume: 34
  start-page: 1
  year: 2020
  end-page: 51
  article-title: Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group
  publication-title: Eye
– volume: 161
  start-page: 459
  year: 2003
  end-page: 60
  article-title: Holey barrier: claudins and the regulation of brain endothelial permeability
  publication-title: J Cell Biol
– volume: 29
  start-page: 1
  year: 2010
  end-page: 18
  article-title: The dynamic nature of Bruch's membrane
  publication-title: Prog Retin Eye Res
– volume: 184
  start-page: 541
  year: 2014
  end-page: 55
  article-title: Loss of caveolin‐1 causes blood‐retinal barrier breakdown, venous enlargement, and mural cell alteration
  publication-title: Am J Pathol
– volume: 84
  start-page: 1660
  year: 2003
  end-page: 73
  article-title: Paracellular ion channel at the tight junction
  publication-title: Biophys J
– volume: 13
  start-page: 427
  year: 2010
  end-page: 9
  article-title: Association for research in vision and ophthalmology (ARVO)–2010 annual meeting. for sight: the future of eye and vision research–part 1
  publication-title: Idrugs
– volume: 162
  start-page: 126
  year: 2011
  end-page: 35
  article-title: KMUP‐3 attenuates ventricular remodelling after myocardial infarction through eNOS enhancement and restoration of MMP‐9/TIMP‐1 balance
  publication-title: Br J Pharmacol
– volume: 61
  start-page: 1573
  year: 2012
  end-page: 83
  article-title: Protein kinase cbeta phosphorylates occludin regulating tight junction trafficking in vascular endothelial growth factor‐induced permeability
  publication-title: Diabetes
– volume: 2018
  start-page: 8374647
  year: 2018
  article-title: Age‐related macular degeneration: new paradigms for treatment and management of AMD
  publication-title: Oxid Med Cell Longev
– volume: 101
  start-page: 354
  year: 1986
  end-page: 60
  article-title: Retinal fluorescein leakage in retinitis pigmentosa
  publication-title: Am J Ophthalmol
– volume: 37
  start-page: 39
  issue: Suppl 1
  year: 2005
  end-page: 43
  article-title: Pericytes and the pathogenesis of diabetic retinopathy
  publication-title: Horm Metab Res
– volume: 34
  start-page: 306
  year: 2014
  end-page: 12
  article-title: Analysis of the thickness and vascular layers of the choroid in eyes with geographic atrophy using spectral‐domain optical coherence tomography
  publication-title: Retina
– volume: 11
  start-page: 507
  year: 2010
  end-page: 14
  article-title: Targeting the kallikrein‐kinin system as a new therapeutic approach to diabetic retinopathy
  publication-title: Curr Opin Investig Drugs
– volume: 8
  start-page: 13067
  year: 2015
  end-page: 74
  article-title: Effect of caveolin‐1 on the expression of tight junction‐associated proteins in rat glioma‐derived microvascular endothelial cells
  publication-title: Int J Clin Exp Pathol
– volume: 10
  start-page: 64
  year: 2021
  article-title: The impact of oxidative stress on blood‐retinal barrier physiology in age‐related macular degeneration
  publication-title: Cells
– volume: 30
  start-page: 1195
  year: 2020
  end-page: 206
  article-title: Bruch's membrane pathology: a mechanistic perspective
  publication-title: Eur J Ophthalmol
– volume: 57
  start-page: 857
  year: 2005
  end-page: 67
  article-title: The JAM family of proteins
  publication-title: Adv Drug Deliv Rev
– volume: 55
  start-page: 480
  year: 2006
  end-page: 6
  article-title: Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation
  publication-title: Diabetes
– volume: 84
  start-page: 869
  year: 2004
  end-page: 901
  article-title: Endothelial cell‐to‐cell junctions: molecular organization and role in vascular homeostasis
  publication-title: Physiol Rev
– volume: 34
  start-page: 349
  year: 2012
  end-page: 52
  article-title: Blockade of early and late retinal biochemical alterations associated with diabetes development by the selective bradykinin B1 receptor antagonist R‐954
  publication-title: Peptides
– volume: 90
  start-page: 703
  year: 2010
  end-page: 10
  article-title: Macromolecular diffusion characteristics of ageing human Bruch's membrane: implications for age‐related macular degeneration (AMD)
  publication-title: Exp Eye Res
– volume: 2010
  start-page: 190724
  year: 2010
  article-title: The retinal pigment epithelium: something more than a constituent of the blood‐retinal barrier–implications for the pathogenesis of diabetic retinopathy
  publication-title: J Biomed Biotechnol
– volume: 31
  start-page: 1360
  year: 2011
  end-page: 7
  article-title: Hypoxia inducible factor‐dependent regulation of angiogenesis by nitro‐fatty acids
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 38
  start-page: 1309
  year: 2020
  end-page: 18
  article-title: Voretigene neparvovec for treating inherited retinal dystrophies caused by RPE65 gene mutations: an evidence review group perspective of a NICE highly specialised technology appraisal
  publication-title: Pharmacoeconomics
– volume: 63
  start-page: 329
  year: 2018
  end-page: 39
  article-title: Treatment of cystoid macular edema secondary to retinitis pigmentosa: a systematic review
  publication-title: Surv Ophthalmol
– volume: 39
  start-page: 9689
  year: 2019
  end-page: 701
  article-title: Disrupted blood‐retina lysophosphatidylcholine transport impairs photoreceptor health but not visual signal transduction
  publication-title: J Neurosci
– volume: 67
  start-page: 763
  year: 2019
  end-page: 71
  article-title: Coats disease: An overview of classification, management and outcomes
  publication-title: Indian J Ophthalmol
– volume: 258
  start-page: 195
  year: 2007
  end-page: 234
  article-title: Development and role of tight junctions in the retinal pigment epithelium
  publication-title: Int Rev Cytol
– volume: 8
  year: 2013
  article-title: High glucose attenuates shear‐induced changes in endothelial hydraulic conductivity by degrading the glycocalyx
  publication-title: PLoS One
– volume: 21
  start-page: S3
  issue: Suppl 6
  year: 2011
  end-page: 9
  article-title: Blood‐retinal barrier
  publication-title: Eur J Ophthalmol
– volume: 122
  start-page: 123
  year: 2014
  end-page: 31
  article-title: Molecular analysis of blood‐retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy
  publication-title: Exp Eye Res
– volume: 9
  year: 2014
  article-title: Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood‐retinal barrier in diabetic retinopathy
  publication-title: PLoS One
– volume: 370
  start-page: 20140195
  year: 2015
  article-title: Glial cell regulation of neuronal activity and blood flow in the retina by release of gliotransmitters
  publication-title: Philos Trans R Soc Lond B Biol Sci
– volume: 86
  start-page: 159
  year: 2005
  end-page: 208
  article-title: Formation of bradykinin: a major contributor to the innate inflammatory response
  publication-title: Adv Immunol
– volume: 301
  start-page: H2235
  year: 2011
  end-page: 45
  article-title: Shedding of the endothelial glycocalyx in arterioles, capillaries, and venules and its effect on capillary hemodynamics during inflammation
  publication-title: Am J Physiol Heart Circ Physiol
– volume: 283
  start-page: C142
  year: 2002
  end-page: 7
  article-title: Claudins create charge‐selective channels in the paracellular pathway between epithelial cells
  publication-title: Am J Physiol Cell Physiol
– volume: 10
  start-page: 20
  year: 2016
  article-title: Brain and retinal pericytes: origin, function and role
  publication-title: Front Cell Neurosci
– volume: 87
  start-page: 243
  year: 2010
  end-page: 53
  article-title: Role of GTPases in control of microvascular permeability
  publication-title: Cardiovasc Res
– volume: 94
  start-page: e5
  issue: 581–594
  year: 2017
  article-title: Blood‐brain barrier permeability is regulated by lipid transport‐dependent suppression of caveolae‐mediated transcytosis
  publication-title: Neuron
– volume: 48
  start-page: 18
  year: 2007
  end-page: 26
  article-title: Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid
  publication-title: Invest Ophthalmol vis Sci
– volume: 13
  start-page: 991
  year: 2019
  article-title: Retinal phenotype in the rd9 mutant mouse, a model of X‐linked RP
  publication-title: Front Neurosci
– volume: 21
  start-page: 1200
  year: 2010
  end-page: 13
  article-title: Tight junction‐associated MARVEL proteins marveld3, tricellulin, and occludin have distinct but overlapping functions
  publication-title: Mol Biol Cell
– volume: 1672
  start-page: 50
  year: 2017
  end-page: 7
  article-title: Retinal metabolism: a comparative look at energetics in the retina
  publication-title: Brain Res
– ident: e_1_2_22_27_1
  doi: 10.1016/j.preteyeres.2011.06.002
– ident: e_1_2_22_36_1
  doi: 10.1093/cvr/cvq086
– ident: e_1_2_22_5_1
  doi: 10.1016/j.preteyeres.2009.08.003
– ident: e_1_2_22_45_1
  doi: 10.1006/bbrc.1998.9790
– ident: e_1_2_22_53_1
  doi: 10.1038/nature13324
– ident: e_1_2_22_72_1
  doi: 10.1172/jci.insight.130273
– volume: 8
  start-page: 13067
  year: 2015
  ident: e_1_2_22_49_1
  article-title: Effect of caveolin‐1 on the expression of tight junction‐associated proteins in rat glioma‐derived microvascular endothelial cells
  publication-title: Int J Clin Exp Pathol
– ident: e_1_2_22_8_1
  doi: 10.1152/physrev.00021.2004
– ident: e_1_2_22_50_1
  doi: 10.1083/jcb.150.5.1057
– ident: e_1_2_22_20_1
  doi: 10.3390/ijms21051636
– ident: e_1_2_22_44_1
  doi: 10.1038/nrm3512
– ident: e_1_2_22_23_1
  doi: 10.1016/j.preteyeres.2013.02.001
– ident: e_1_2_22_106_1
  doi: 10.1016/j.exer.2006.01.032
– ident: e_1_2_22_96_1
  doi: 10.2174/09298673113209990022
– volume: 10
  start-page: 913
  year: 1995
  ident: e_1_2_22_104_1
  article-title: Blood‐retinal barrier breakdown in retinitis pigmentosa: light and electron microscopic immunolocalization
  publication-title: Histol Histopathol
– volume: 150
  start-page: 329
  year: 1997
  ident: e_1_2_22_91_1
  article-title: Interleukin‐1 beta‐induced disruption of the retinal vascular barrier of the central nervous system is mediated through leukocyte recruitment and histamine
  publication-title: Am J Pathol
– ident: e_1_2_22_13_1
  doi: 10.1146/annurev-vision-091517-034018
– ident: e_1_2_22_74_1
  doi: 10.2337/diacare.27.2007.S84
– ident: e_1_2_22_58_1
  doi: 10.1152/physrev.00019.2012
– ident: e_1_2_22_107_1
  doi: 10.3389/fnins.2019.00991
– volume: 13
  start-page: 336
  year: 1976
  ident: e_1_2_22_113_1
  article-title: Flat preparations of the retinal vessels in Coats' disease
  publication-title: J Pediatr Ophthalmol
– ident: e_1_2_22_11_1
  doi: 10.1155/2010/190724
– ident: e_1_2_22_76_1
  doi: 10.1038/s41433-020-0961-6
– ident: e_1_2_22_94_1
  doi: 10.2337/diabetes.53.4.1104
– ident: e_1_2_22_103_1
  doi: 10.1016/S0140-6736(06)69740-7
– ident: e_1_2_22_34_1
  doi: 10.1016/j.addr.2005.01.005
– ident: e_1_2_22_14_1
  doi: 10.1186/s40662-021-00239-1
– ident: e_1_2_22_66_1
  doi: 10.3390/ijms21124271
– ident: e_1_2_22_51_1
  doi: 10.1038/ng.3311
– ident: e_1_2_22_46_1
  doi: 10.1076/0271-3683(200008)2121-VFT637
– volume: 94
  start-page: e5
  issue: 581
  year: 2017
  ident: e_1_2_22_54_1
  article-title: Blood‐brain barrier permeability is regulated by lipid transport‐dependent suppression of caveolae‐mediated transcytosis
  publication-title: Neuron
– ident: e_1_2_22_90_1
  doi: 10.2337/db09-1606
– ident: e_1_2_22_38_1
  doi: 10.1023/A:1002192829817
– ident: e_1_2_22_75_1
  doi: 10.1007/s00018-019-03177-3
– ident: e_1_2_22_77_1
  doi: 10.1136/bmjopen-2012-002269
– ident: e_1_2_22_41_1
  doi: 10.1016/S0074-7696(07)58004-6
– ident: e_1_2_22_100_1
  doi: 10.1371/journal.pone.0052152
– ident: e_1_2_22_7_1
  doi: 10.3390/cells10010064
– ident: e_1_2_22_17_1
  doi: 10.3389/fncel.2016.00020
– ident: e_1_2_22_95_1
  doi: 10.1055/s-2005-861361
– ident: e_1_2_22_26_1
  doi: 10.1152/ajpcell.00547.2002
– ident: e_1_2_22_60_1
  doi: 10.1038/jcbfm.2013.230
– ident: e_1_2_22_4_1
  doi: 10.5301/EJO.2010.6049
– ident: e_1_2_22_47_1
  doi: 10.1016/j.ajpath.2015.11.019
– ident: e_1_2_22_43_1
  doi: 10.1007/978-981-13-7647-4_1
– ident: e_1_2_22_115_1
  doi: 10.1136/bjo.55.5.289
– ident: e_1_2_22_30_1
  doi: 10.1083/jcb.200302070
– ident: e_1_2_22_22_1
  doi: 10.1146/annurev.cellbio.22.010305.104219
– ident: e_1_2_22_37_1
  doi: 10.1083/jcb.200304039
– ident: e_1_2_22_105_1
  doi: 10.1016/0002-9394(86)90831-7
– ident: e_1_2_22_31_1
  doi: 10.1091/mbc.E09-08-0734
– ident: e_1_2_22_98_1
  doi: 10.1152/ajpheart.00803.2011
– ident: e_1_2_22_35_1
  doi: 10.1152/physrev.00035.2003
– ident: e_1_2_22_110_1
  doi: 10.4103/ijo.IJO_449_19
– ident: e_1_2_22_25_1
  doi: 10.1186/gb-2009-10-8-235
– ident: e_1_2_22_67_1
  doi: 10.1177/1120672120919337
– ident: e_1_2_22_29_1
  doi: 10.1167/iovs.10-5984
– ident: e_1_2_22_112_1
  doi: 10.4103/ijo.IJO_841_19
– ident: e_1_2_22_21_1
  doi: 10.1016/j.preteyeres.2015.06.003
– ident: e_1_2_22_62_1
  doi: 10.1016/S0140-6736(18)31550-2
– ident: e_1_2_22_40_1
  doi: 10.1016/j.preteyeres.2017.10.006
– ident: e_1_2_22_33_1
  doi: 10.1074/jbc.M905251199
– ident: e_1_2_22_80_1
  doi: 10.1038/bjp.2008.48
– ident: e_1_2_22_3_1
  doi: 10.1167/iovs.03-0913
– ident: e_1_2_22_39_1
  doi: 10.1159/000455809
– ident: e_1_2_22_19_1
  doi: 10.1038/nrn1824
– ident: e_1_2_22_42_1
  doi: 10.1002/jps.22610
– ident: e_1_2_22_61_1
  doi: 10.1016/S2214-109X(13)70145-1
– ident: e_1_2_22_84_1
  doi: 10.1159/000078617
– ident: e_1_2_22_64_1
  doi: 10.1155/2018/8374647
– ident: e_1_2_22_69_1
  doi: 10.1371/journal.pone.0144156
– volume: 11
  start-page: 507
  year: 2010
  ident: e_1_2_22_81_1
  article-title: Targeting the kallikrein‐kinin system as a new therapeutic approach to diabetic retinopathy
  publication-title: Curr Opin Investig Drugs
– ident: e_1_2_22_59_1
  doi: 10.1073/pnas.0808698106
– ident: e_1_2_22_108_1
  doi: 10.1007/s40273-020-00953-z
– volume: 13
  start-page: 427
  year: 2010
  ident: e_1_2_22_82_1
  article-title: Association for research in vision and ophthalmology (ARVO)–2010 annual meeting. for sight: the future of eye and vision research–part 1
  publication-title: Idrugs
– ident: e_1_2_22_79_1
  doi: 10.1016/S0065-2776(04)86005-X
– ident: e_1_2_22_28_1
  doi: 10.1152/ajpcell.00038.2002
– ident: e_1_2_22_6_1
  doi: 10.1016/j.exer.2010.02.013
– ident: e_1_2_22_78_1
  doi: 10.1515/hsz-2012-0316
– ident: e_1_2_22_56_1
  doi: 10.1167/iovs.06-0619
– ident: e_1_2_22_12_1
  doi: 10.1016/j.preteyeres.2020.100878
– ident: e_1_2_22_102_1
  doi: 10.1111/j.1476-5381.2010.01024.x
– ident: e_1_2_22_15_1
  doi: 10.1007/s00417-016-3548-y
– ident: e_1_2_22_85_1
  doi: 10.1038/nm1534
– ident: e_1_2_22_2_1
  doi: 10.1016/j.brainres.2017.07.025
– ident: e_1_2_22_93_1
  doi: 10.1167/iovs.06-1358
– ident: e_1_2_22_57_1
  doi: 10.1016/S0006-3495(03)74975-3
– ident: e_1_2_22_71_1
  doi: 10.1016/j.pneurobio.2011.05.011
– ident: e_1_2_22_87_1
  doi: 10.1074/jbc.274.33.23463
– ident: e_1_2_22_92_1
  doi: 10.1371/journal.pone.0108508
– ident: e_1_2_22_18_1
  doi: 10.1098/rstb.2014.0195
– ident: e_1_2_22_63_1
  doi: 10.1016/j.preteyeres.2016.04.003
– ident: e_1_2_22_109_1
  doi: 10.1016/j.survophthal.2017.09.009
– ident: e_1_2_22_86_1
  doi: 10.1161/ATVBAHA.111.224626
– ident: e_1_2_22_88_1
  doi: 10.2337/db11-1367
– volume: 31
  start-page: 999
  year: 1990
  ident: e_1_2_22_16_1
  article-title: Pericyte coverage of retinal and cerebral capillaries
  publication-title: Invest Ophthalmol vis Sci
– ident: e_1_2_22_24_1
  doi: 10.1038/nrm1357
– ident: e_1_2_22_9_1
  doi: 10.2174/156652410793937813
– ident: e_1_2_22_89_1
  doi: 10.1242/jcs.111.13.1853
– ident: e_1_2_22_55_1
  doi: 10.1523/JNEUROSCI.1142-19.2019
– ident: e_1_2_22_97_1
  doi: 10.2337/diabetes.55.02.06.db05-1103
– ident: e_1_2_22_10_1
  doi: 10.1016/S0002-9440(10)61231-X
– ident: e_1_2_22_101_1
  doi: 10.1371/journal.pone.0078954
– ident: e_1_2_22_48_1
  doi: 10.1016/j.ajpath.2013.10.022
– ident: e_1_2_22_111_1
  doi: 10.3928/01913913-20190716-01
– ident: e_1_2_22_32_1
  doi: 10.1083/jcb.141.2.397
– ident: e_1_2_22_73_1
  doi: 10.1016/j.ophtha.2021.04.027
– ident: e_1_2_22_99_1
  doi: 10.1016/j.exer.2014.03.005
– ident: e_1_2_22_65_1
  doi: 10.3390/jcm3041302
– ident: e_1_2_22_83_1
  doi: 10.1016/j.peptides.2012.02.008
– ident: e_1_2_22_52_1
  doi: 10.1074/jbc.M116.721340
– ident: e_1_2_22_68_1
  doi: 10.1097/IAE.0b013e3182993e09
– ident: e_1_2_22_114_1
  doi: 10.1186/1746-1596-1-24
– ident: e_1_2_22_70_1
  doi: 10.1016/j.exer.2019.05.026
SSID ssj0035499
Score 2.6922576
SecondaryResourceType review_article
Snippet The blood–retina barrier (BRB) is the term used to define the properties of the retinal capillaries and the retinal pigment epithelium (RPE), which separate...
The blood-retina barrier (BRB) is the term used to define the properties of the retinal capillaries and the retinal pigment epithelium (RPE), which separate...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 878
SubjectTerms barrier
Blood
Blood circulation
Blood-Retinal Barrier - metabolism
Capillaries
Diabetes mellitus
Diabetic retinopathy
Edema
Endothelial cells
Endothelial Cells - metabolism
Epithelium
Eye diseases
Humans
Macular degeneration
Maintenance
Microenvironments
Microvasculature
Molecular structure
neurovascular
pathophysiology
Retina
Retina - metabolism
Retinal Diseases - metabolism
Retinal pigment epithelium
Retinal Pigment Epithelium - metabolism
Retinopathy
Structural integrity
Structure-function relationships
tight junction
tight junctions
Title The blood–retina barrier in health and disease
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Ffebs.16330
https://www.ncbi.nlm.nih.gov/pubmed/34923749
https://www.proquest.com/docview/2776929453
https://www.proquest.com/docview/2612037712
https://www.proquest.com/docview/2811979422
Volume 290
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1faxQxEB9KfdAXq61_rtYSqQgKe2w3c8kGfLlrexShPqiFe5El2U2g2G5L7-6hPvkd_IZ-Emeyf7RWCvq2kNklm2SS32RmfgPwkpMbQ2q4uAvaBAnwJ06FlH3wNmSlUdZzovDRe3V4jO9mo9kKvO1yYRp-iP7CjTUj7tes4NbNf1Py4N18SGhCssHOwVqMiD703FGSDZ8mGzJLUOGs5SblMJ5fr14_jW5AzOuINR450zX43HW2iTT5Mlwu3LD8-geP4__-zQO432JRMW4Wz0NY8fU6bIxrssPPrsQrEaND47X7Otzd6yrDbUBKa0vEiPcf375zFmRthbOXXPtOnNSiSa0Utq5E6_55BMfTg097h0lbeSEp0ZA9iWWKVVUZS9qdBySTY-TQ610MlVIW86wqURHUrHI7cjpHqVzG5G9Bm4zarXwMq_V57Z-CQC-lztMgPX0iD9740hFkNJYMRd5eBvC6m4GibGnJuTrGadGZJzw0RRyaAez0shcNGcdfpba6iSxahZwXmdaKkCCO5ABe9M00buwfsbU_X5IMob1Uar2b3SKTs9_VYEYyT5pF0neFiR6lRjOAN3Gqb-ljMT2YfIxPm_8i_Azucbn7Jmp8C1YXl0v_nEDRwm3DnfFkfzLdjkrwE7tWBiM
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB6hcigXWlp-lhYwAiGBlFVqz9rxsVRdLdD2AK20t8hObAm1TVF39wAn3oE35EmYcbKBAqoEt0ieRI7tsb_xzHwD8JyTG2NuubgLugwJ8Gdex5x98C7KymoXOFH48EhPTvDtdDTtYnM4F6blh-gv3Fgz0n7NCs4X0r9oeQx-NiQ4ochiv8klvZNF9b5nj1Js-rT5kDJDjdOOnZQDeX6-e_U8-gNkXsWs6dAZr7WVVWeJq5BjTU6Hi7kfVl9-Y3L87_9Zh9sdHBW77fq5AzdCswGbuw2Z4uefxQuRAkTTzfsGrO4ti8NtQk7LS6Sg9-9fv3EiZOOEd5dc_k58bESbXSlcU4vOA3QXTsb7x3uTrCu-kFVoyaTEKse6rq0jBS8iktUx8hjMDsZaa4eFrCvUhDbrwo28KVBpL5n_LRorqd2pe7DSXDThAQgMSpkijyrQJ4oYbKg8oUbryFbkHWYAL5dTUFYdMzkXyDgrlxYKD02ZhmYAz3rZTy0fx1-ltpczWXY6OSulMZrAII7UAJ72zTRu7CJxTbhYkAwBvlwZsyOvkSnY9WpRksz9dpX0XWGuR2XQDuBVmutr-liO919_SE8P_0X4CaxOjg8PyoM3R--24JYkzNUGkW_DyvxyER4RRpr7x0kTfgDYDgjM
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1baxUxEB5KBfXFS-vlaNWIIijsYZvMSTbgS217qLciauG8yJLsJlCq29Ke86BP_gf_ob_EmexFq1LQt4XMLtkkk3yTmfkG4CEnN8bccnEXdBkS4M-8jjn74F2UldUucKLw6129s4cvZpPZEjztc2Fafojhwo01I-3XrOBHdfxFyWPwJ2NCE4oM9nOo84LX9NbbgTxKseXTpkPKDDXOOnJSjuP5-e7p4-gPjHkasqYzZ3oZPvS9bUNNDsaLuR9XX34jcvzf37kClzowKjba1XMVlkKzAqsbDRninz6LRyKFh6Z79xW4sNmXhluFnBaXSCHv379-4zTIxgnvjrn4ndhvRJtbKVxTi87_cw32ptvvN3eyrvRCVqElgxKrHOu6to7Uu4hINsfEYzDrGGutHRayrlAT1qwLN_GmQKW9ZPa3aKykdqeuw3Jz2ISbIDAoZYo8qkCfKGKwofKEGa0jS5H3lxE87megrDpeci6P8bHs7RMemjINzQgeDLJHLRvHX6XW-oksO408KaUxmqAgTtQI7g_NNG7sIHFNOFyQDMG9XBmzLs-QKdjxalGSzI12kQxdYaZHZdCO4Ema6jP6WE63n71LT7f-RfgenH-zNS1fPd99eRsuSgJcbQT5GizPjxfhDgGkub-b9OAHzssHhA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+blood%E2%80%93retina+barrier+in+health+and+disease&rft.jtitle=The+FEBS+journal&rft.au=Fionn+O%E2%80%99Leary&rft.au=Campbell%2C+Matthew&rft.date=2023-02-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=1742-464X&rft.eissn=1742-4658&rft.volume=290&rft.issue=4&rft.spage=878&rft.epage=891&rft_id=info:doi/10.1111%2Ffebs.16330&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-464X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-464X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-464X&client=summon